Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Regression: from bad to better?
- Mouse model of regression (1)
- Absence of macrophages after regression
- Mouse model of regression (2)
- Rapid exit of monocyte-derived cells
- First hint of macrophage heterogeneity
- Heterogeneity of cell types in arterial lesions
- Example of LCM of macrophage foam cells
- Blocking the CCR7 pathway blocks regression
- Summary of part 1
- Lipoprotein changes from apoE-/- to WT mice
- HDL and vascular protection
- Model to test selective normalization of HDL-C
- Normalization of HDL-C promotes regression
- Regression is impaired
- HDL modulates CCR7 levels
- Molecular mechanism for CCR7 regulation
- Evidence for SRE-activation in vivo
- Summary of part 2
- Part 3: changes in macrophage polarization
- Classification of macrophages in tissues
- HDL regulates the inflammatory state (1)
- HDL regulates the inflammatory state (2)
- HDL enriches CD68+ cells in M2 markers (1)
- HDL enriches CD68+ cells in M2 markers (2)
- Are the changes model dependent?
- MiR-33 negatively regulates ABCA1 expression
- Predicted effects of blocking miR-33
- miR-33 in LDLr-/- mice regulates HDL Levels
- Less inflammation in plaque macrophages
- Some models of macrophage "plasticity"
- Summary of part 3
- Overall summary (1)
- Overall summary (2)
- Acknowledgements
Topics Covered
- Novel research tools
- Developing mouse models to study atherosclerosis regression
- Developing the tools to analyze macrophage trafficking and molecular phenotypes in vivo
- The regression of atherosclerosis by HDL due to its effects on the quantity and phenotype of macrophages in plaques
- Macrophage polarization
- Plasticity during atherosclerosis regression
- Models for the enrichment in cells in the M2 state
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Fisher, E. (2012, June 11). Macrophage heterogeneity in atherosclerosis regression [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/IODW9558.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Edward Fisher, Consultant: Merck; Speaker’s Bureau: Merck; Grant/Research Support (Principal Investigator): Merck